Stéphanie E. Reitsma

New insights in Type I and <scp>II CD</scp>20 antibody mechanisms‐of‐action with a panel of novel <scp>CD</scp>20 antibodies

Saskia Meyer, Mitchell Evers, J.H. Marco Jansen et al. · British Journal of Haematology · 2018 · 63 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice

Anh T. P. Ngo, Kelley R. Jordan, Paul Müeller et al. · Journal of Thrombosis and Haemostasis · 2021 · 55 citations · Full text

Medicine, Pathobiology, Pharmacology +16

Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H

Cristina Puy, Jiaqing Pang, Stéphanie E. Reitsma et al. · The Journal of Immunology · 2021 · 50 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo

Jevgenia Zilberman‐Rudenko, Stéphanie E. Reitsma, Cristina Puy et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2018 · 42 citations · Full text

Medicine, Hematology, Pathobiology +17

Removal of the C-Terminal Domains of ADAMTS13 by Activated Coagulation Factor XI induces Platelet Adhesion on Endothelial Cells under Flow Conditions

Kathleen S. Garland, Stéphanie E. Reitsma, Toshiaki Shirai et al. · Frontiers in Medicine · 2017 · 37 citations · Full text

Medicine, Biochemistry, Molecular Biology +17